Gene · 1874
Papers2,563
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,563
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma. | Cancer Lett | 2022 | 36087682 | PubTator, text mining | PubMed |
| Decoding the Spermatogenesis Program: New Insights from Transcriptomic Analyses. | Annu Rev Genet | 2022 | 36070560 | PubTator, text mining | PubMed |
| Regulating the regulator: a survey of mechanisms from transcription to translation controlling expression of mammalian cell cycle kinase Aurora A. | Open Biol | 2022 | 36067794 | PubTator, text mining | PubMed |
Proteomic profiling reveals neuronal ion channel dysregulation and cellular responses to DNA damage-induced cell cycle arrest and senescence in human neuroblastoma SH-SY5Y cells exposed to cypermethrin. | Neurotoxicology | 2022 | 36063984 | PubTator, text mining | PubMed |
| Role of endometrial microRNAs in repeated implantation failure (mini-review). | Front Cell Dev Biol | 2022 | 36060804 | PubTator, text mining | PubMed |
| Cellular and molecular profiles of larval and adult Xenopus corneal epithelia resolved at the single-cell level. | Dev Biol | 2022 | 36049533 | PubTator, text mining | PubMed |
| The Human Glyoxalase Gene Family in Health and Disease. | Chem Res Toxicol | 2022 | 36048613 | PubTator, text mining | PubMed |
| Methylation status of TK1 correlated with immune infiltrates in prostate cancer. | Front Genet | 2022 | 36035114 | PubTator, text mining | PubMed |
| Molecular Threat of Splicing Factor Mutations to Myeloid Malignancies and Potential Therapeutic Modulations. | Biomedicines | 2022 | 36009519 | PubTator, text mining | PubMed |
| Context-dependent CpG methylation directs cell-specific binding of transcription factor ZBTB38. | Epigenetics | 2022 | 36000449 | PubTator, text mining | PubMed |
| Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics. | Ther Adv Med Oncol | 2022 | 35983027 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells. | Int J Biol Sci | 2022 | 35982899 | PubTator, text mining | PubMed |
| Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progression. | Mol Cell | 2022 | 35981542 | PubTator, text mining | PubMed |
| Identification of critical genes associated with radiotherapy resistance in cervical cancer by bioinformatics. | Front Oncol | 2022 | 35965520 | PubTator, text mining | PubMed |
| GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma. | Medicine (Baltimore) | 2022 | 35960100 | PubTator, text mining | PubMed |
| Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus. | Nat Commun | 2022 | 35948546 | PubTator, text mining | PubMed |
| Crosstalk between the CBM complex/NF-κB and MAPK/P27 signaling pathways of regulatory T cells contributes to the tumor microenvironment. | Front Cell Dev Biol | 2022 | 35927985 | PubTator, text mining | PubMed |
| E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription. | Mol Carcinog | 2022 | 35924788 | PubTator, text mining | PubMed |
| Granulin as an important immune molecule involved in lamprey tissue repair and regeneration by promoting cell proliferation and migration. | Cell Mol Biol Lett | 2022 | 35907821 | PubTator, text mining | PubMed |
| Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis. | Ann Rheum Dis | 2022 | 35906002 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1874/papers?page=18